Post: Recent publications- Anne Peters, MD

Recent publications (2021):
Efficacy and Safety of Sotagliflozin in Patients With Type 2 Diabetes and Severe Renal Impairment. Diabetes Obes Metab. 2021 Aug 02. Cherney DZI, Ferrannini E, Umpierrez GE, Peters AL, Rosenstock J, Carroll AK, Lapuerta P, Banks P, Agarwal R. PMID: 34338408. View in PubMed- https://www.ncbi.nlm.nih.gov/pubmed/34338408

Patient-reported outcomes in adults with type 1 diabetes in global real-world clinical practice: The SAGE study. Diabetes Obes Metab. 2021 08; 23(8):1892-1901. Wilmot EG, Close KL, Jurišic-Eržen D, Bruttomesso D, Ampudia-Blasco FJ, Bosnyak Z, Roborel de Climens A, Bigot G, Peters AL, Renard E, Berard L, Calliari LE, Seufert J. PMID: 33914401. View in PubMed- https://www.ncbi.nlm.nih.gov/pubmed/33914401

Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial. JAMA. 2021 06 08; 325(22):2262-2272. Martens T, Beck RW, Bailey R, Ruedy KJ, Calhoun P, Peters AL, Pop-Busui R, Philis-Tsimikas A, Bao S, Umpierrez G, Davis G, Kruger D, Bhargava A, Young L, McGill JB, Aleppo G, Nguyen QT, Orozco I, Biggs W, Lucas KJ, Polonsky WH, Buse JB, Price D, Bergenstal RM, MOBILE Study Group . PMID: 34077499. View in PubMed- https://www.ncbi.nlm.nih.gov/pubmed/34077499

Comparison of Protocols to Reduce Diabetic Ketoacidosis in Patients With Type 1 Diabetes Prescribed a Sodium-Glucose Cotransporter 2 Inhibitor. Diabetes Spectr. 2021 Jan; 34(1):42-51. Teng R, Kurian M, Close KL, Buse JB, Peters AL, Alexander CM. PMID: 33627993. View in PubMed- https://www.ncbi.nlm.nih.gov/pubmed/33627993

Share:

More Posts

David Armstrong, PhD, DPM was featured on MedScape

On June 24, Medscape featured commentary by David Armstrong, PhD, DPM, podiatric surgeon with Keck Medicine and professor of surgery and neurological surgery, on treating infected diabetic foot ulcers. Click

Everyday Health quoted Alyssa Dominguez, MD

On June 25, Everyday Health quoted Alyssa Dominguez, MD, endocrinologist with Keck Medicine and clinical assistant professor of medicine (clinician educator), on a study associating semaglutide use with reduced risk of